Показано 0 из 0
Дата |
---|
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.35
|
4.40
|
4.41
|
4.21
|
4.535
|
4.35
|
|
|
6 015 456.42
|
10 516.00
|
4.32
|
4.40
|
4.50
|
4.18
|
4.55
|
4.37
|
|
|
12 931 469.89
|
14 544.00
|
4.44
|
4.49
|
4.30
|
4.22
|
4.93
|
4.41
|
|
|
30 279 457.29
|
28 721.00
|
4.39
|
4.43
|
3.94
|
3.91
|
4.57
|
4.40
|
|
|
26 944 283.53
|
27 635.00
|
4.01
|
4.03
|
3.88
|
3.84
|
4.51
|
3.98
|
|
|
39 630 576.73
|
39 044.00
|
3.87
|
3.90
|
3.45
|
3.36
|
4.02
|
3.89
|
|
|
71 634 728.18
|
73 024.00
|
3.26
|
3.28
|
2.95
|
2.82
|
4.76
|
3.30
|
|
|
568 847 574.43
|
559 813.00
|
2.66
|
2.76
|
1.94
|
1.87
|
1.995
|
1.93
|
|
|
6 126 421.97
|
13 485.00
|
1.90
|
2.04
|
1.88
|
1.8244
|
1.91
|
1.88
|
|
|
1 846 983.56
|
5 144.00
|
1.91
|
2.04
|
1.92
|
1.88
|
2.04
|
1.89
|
|
|
2 103 822.01
|
6 020.00
|
Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. The Company operates in two divisions: BioDefense Division and BioSciences Division. It derived substantially all of its product revenues from sales of BioThrax to the United States government, specifically and the United States Department of Health and Human Services (HHS), as well as the United States Department of Defense (DoD).